Vilaró M T, Wiederhold K H, Palacios J M, Mengod G
Sandoz Pharma Ltd, Basel, Switzerland.
Synapse. 1992 Jul;11(3):171-83. doi: 10.1002/syn.890110302.
We have used autoradiographic techniques to examine the characteristics and distribution of the binding of reported selective M2 muscarinic ligands and compared them with the distribution of cells expressing mRNAs for the different subtypes of muscarinic receptors. Our results suggest that the M2 ligands used in the present study ([3H]OXO-M, ([3H]OXO-M,[3H]AF-DX384,AF-DX116, methoctramine) also recognize M4 receptors present in regions such as the striatum and olfactory tubercle. This is supported by 1) relative abundances of the different transcripts, with m2 mRNA being very scarce and m4 mRNA very abundant in these regions; 2) comparison of the pharmacological characteristics of M2-ligand binding sites in brain areas selected by their exclusive expression of M2 receptors versus areas enriched in M4 receptors. An important conclusion of these studies is that none of the muscarinic radioligands available at the present time appears to label specifically a single muscarinic receptor subtype population. Areas are suggested where autoradiographic techniques can be helpful in elucidating the subtype selectivity of existing and new ligands.
我们运用放射自显影技术研究了已报道的选择性M2毒蕈碱配体的结合特性与分布,并将其与表达不同毒蕈碱受体亚型mRNA的细胞分布进行了比较。我们的结果表明,本研究中使用的M2配体([3H]氧代甲胆碱、[3H]AF-DX384、AF-DX116、甲氧基氨)也能识别存在于纹状体和嗅结节等区域的M4受体。这得到了以下几点的支持:1)不同转录本的相对丰度,在这些区域m2 mRNA非常稀少而m4 mRNA非常丰富;2)通过比较仅表达M2受体的脑区与富含M4受体的脑区中M2配体结合位点的药理学特性。这些研究的一个重要结论是,目前可用的毒蕈碱放射性配体似乎都不能特异性标记单一的毒蕈碱受体亚型群体。文中指出了放射自显影技术在阐明现有和新配体的亚型选择性方面可能有用的领域。